Biomarkers

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/16 (2006.01) C07K 14/58 (2006.01) C07K 16/26 (2006.01) G01N 33/483 (2006.01) G01N 33/53 (2006.01) G01N 33/543 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2716280

The invention provides methods for predicting, diagnosing or monitoring acute cardiac disorders, cardiac trans-plant rejection, or distinguishing acute cardiac disorders from pulmonary disorders, by measuring ANP signal peptide levels in a sample taken from a subject shortly after onset of, or presentation with the disorder of transplant rejection. Also provided are anti-bodies useful in the methods of the invention.

Linvention concerne des procédés de prédiction, de diagnostic ou de surveillance de troubles cardiaques aigus ou dun rejet dune transplantation cardiaque ou distinction entre des troubles cardiaques aigus et des troubles pulmonaires, en mesurant les taux de peptides du signal ANP dans un échantillon prélevé chez un sujet peu après le début du, ou présentant le, rejet dune transplantation. Linvention concerne également des anticorps utiles dans ces procédés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1360868

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.